June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Somatostatin Receptor-2 Expression in Sebaceous Carcinoma of the Ocular Adnexae
Author Affiliations & Notes
  • Sander R Dubovy
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
  • Maria Paula Fernandez
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
  • Jan Paul Ulloa
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
  • Richard K Lee
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
  • Mehrdad Nadji
    Pathology, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Norman L. Block
    Pathology, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Andrew V. Schally
    Pathology, University of Miami Miller School of Medicine, Miami, Florida, United States
    Pathology, Veterans Administration Hospital, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Sander Dubovy, None; Maria Paula Fernandez, None; Jan Ulloa, None; Richard Lee, None; Mehrdad Nadji, None; Norman Block, None; Andrew Schally, None
  • Footnotes
    Support  Supported by NIH Center Core Grant P30EY014801, Research to Prevent Blindness Unrestricted Grant, Department of Defense (DOD- Grant#W81XWH-09-1-0675 and Grant# W81XWH-13-1-0048 ONOVA) and the Florida Lions Eye Bank
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3362. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Sander R Dubovy, Maria Paula Fernandez, Jan Paul Ulloa, Richard K Lee, Mehrdad Nadji, Norman L. Block, Andrew V. Schally; Somatostatin Receptor-2 Expression in Sebaceous Carcinoma of the Ocular Adnexae. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3362.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Somatostatin receptors are high affinity surface receptors that have shown to be expressed in different organs, tissues and different tumors. Somatostatin Receptor subtype-2 (SSTR2) specifically, has shown to mediate inhibition of cell proliferation and apoptosis. The purpose of this study was to evaluate the expression of SST receptor 2 (SSTR2) in sebaceous carcinoma of the ocular adnexae.

Methods : The database at the Florida Lions Ocular Pathology Laboratory was searched for surgical specimens diagnosed with Sebaceous Carcinoma on light microscopic examination from 1990 to 2014. A total of three specimens were randomly retrieved. Immunofluorescence was performed using an antibody for SSTR2 (abcam) to evaluate the expression of this receptor within tumor cells of sebaceous carcinomas. Medical records were reviewed for demographics, clinical presentation, recurrence and treatment. One non-neoplastic sebaceous gland specimen was also retrieved, stained and graded following the aforementioned protocol as a control. IRB/Ethics Committee approval from the University of Miami Miller School of Medicine was obtained for this study.

Results : The diagnosis of sebaceous carcinoma was established by light microscopic examination of formalin fixed, paraffin embedded tissue from the eyelids of three patients. All three patients were female between the ages of 66 and 92. The three cases presented as elevated, vascular lid lesions. On histopathological examination, all demonstrated a tumor composed of foamy, basophilic cells with foci of pleomorphism and brisk mitotic activity. Features of pagetoid spread were identified in the specimens. On immunofluorescence, the three tumors demonstrated a strong expression of SSTR2 within tumor cells and areas of pagetoid spread.

Conclusions : This study demonstrates expression of Somatostatin Receptor-2 within tumor cells of sebaceous carcinomas of the ocular adnexae. The presence of this receptor in sebaceous carcinoma of the eyelid may play a role in the pathophysiology of this tumor. The use of SST analogues may potentially be used as new or adjunctive alternatives for the treatment of sebaceous carcinoma of the ocular adnexae.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×